Mohammad Abbas, MD

About the Doctor

Specialty: Neurology | Interventional Pain

Medical School: University of Damascus School of Medicine

Residency and Fellowship Training:
UNM SOM Pain Medicine Fellowship Program
UNM SOM Neurology Residency Program
UNM SOM Internal Medicine Residency Program
UNM SOM Neurosurgery Residency Program

Position: Neurologist | Interventional Pain Specialist

Memberships:
The American Society of Pain & Neuroscience (ASPN)
North American Neuromodulation Society (NANS)
American Society of Interventional Pain Physicians (ASIPP)
American Society of Anesthesiologists (ASA)
American Academy of Neurology (AAN)
American Association of Neuromuscular & Electrodiagnostic Medicine (AANEM) o American Association for the Advancement of Science (AAAS)
American Neurological Association (ANA)
American Physician Scientists Association (APSA)
American Medical Association (AMA)

Languages: English, Arabic (native)

Publication and Oral Presentation:

PUBLICATIONS

Mohammad L, Abbas M, Shuttleworth CW, Carlson AP. “Spreading Depolarization may represent a novel mechanism for delayed fluctuating neurologic deficit after chronic subdural hematoma evacuation.” J Neurosurg 2020 Mar 27;134(3):1294-1302. doi: 10.3171/2020.1.JNS192914.

Carlson AP, Abbas M, Alunday RL, Qeadan F, Shuttleworth CW. “Spreading depolarization in acute brain injury inhibited by ketamine: a prospective, randomized, multiple crossover trial.” J Neurosurg. 2018 May 25:1-7. doi: 10.3171/2017.12. JNS171665.

Bushnaq S, Qeadan F, Thacker T, Abbas M, Carlson PA. “High-risk features of delayed clinical progression in cerebral venous sinus thrombosis: A proposed prediction score for early intervention”. Interventional Neurology, Accepted 2018-02-23.

Carlson PA, Abbas M, Hall P, Taylor C. “Use of a polytetrofluoroethylene coated vascular plug for focal intracranial parent vessel sacrifice for fusiform aneurysm treatment.” Operative Neurosurgery, March, 2017. doi.org/10.1093/ons/opx006.

Shanmugam I*, Abbas M*, Ayoub F, Mirabal S, Bsaili M, Weinstock DM, Tomkinson AE, Hromas R, Shaheen M. “A Role for USP20 in Rad17 Stability and Chk1 Activation” JBC, 2014 Aug 15;289(33):22739-48.
*Both authors contributed equally to this work.

Abbas M; Shanmugam I, Ayoub F, Bsaili M, Mirabal S, Hromas R, Shaheen M. “The Role of the Human Psoralen 4 (hPso4) Protein Complex in Replication Stress and Homologous Recombination” JBC, 2014 May 16;289(20):14009-19.

Lentzsch S, O’Sullivan A, Kennedy RC, Abbas M, Dai L, Pregja SL, Burt S, Boyiadzis M, Roodman GD, Mapara MY, Agha M, Waas J, Shuai Y, Normolle D, Zonder JA. “Combination of bendamustine, lenalidomide, and dexamethasone (BLD) in patients with relapsed or refractory multiple myeloma is feasible and highly effective: results of phase 1/2 open-label, dose escalation study.” Blood, 2012 May 17; 119(20):4608-13

M. Abbas“Renal diseases” under the supervision of Prof, Mhd Imad Osman, M.D. Damascus University Press, June 2002.

PRESENTATIONS
Neuroscience Resident Research Day, UNM SOM, Neuroscience Department, Albuquerque, NM, June 18th, 2021. “Spreading Depolarization: a hidden, targetable neurophysiologic event.” Research Presentation.

Neuroscience Research Day, Brain & Behavioral Health Institute, Albuquerque, NM, March 15th, 2018. “Ketamine does not affect intracranial pressure in patients with brain injury but effectively suppresses cortical spreading depolarization.” Poster Presentation, Abstract # 93.

Neuroscience Research Day. Albuquerque, NM, June 8, 2018. “CSD2 (Cortical spreading depolarizations in chronic subdural hematoma patients after evacuation) Clinical Trial: Interim Analysis”.

International Conference on Spreading Depolarizations. Boca Raton, FL, Sept 22, 2018. “CSD2 (Cortical Spreading Depolarization in Chronic Subdural Hematoma Patients after evacuation) Trial”.

American Association of Neurological Surgeons (AANS), 2018 New Orleans, Louisiana, April 28 to May 02. “Observation of Cortical Spreading Depolarization after Chronic Subdural Hematoma Evacuation.” Plenary Session Poster presentation # 725.

Neuroscience Research Day. Albuquerque, NM, June 16, 2017. “CSD2 (Cortical spreading depolarizations in chronic subdural hematoma patients after evacuation” Clinical Trial: Interim Analysis.

11th Annual Neuroscience Research Day, Albuquerque, NM, June 10, 2016. “Interim Result of the Spreading Depolarization and Ketamine Suppression (SAKS) Trial.” Poster Presentation, Abstract # 12.

Gordon Research Confrences: DNA Damage, Mutation & Cancer, 2012 Ventura, California, Mar 25th to 30th 2012 “A role of human PSO4 in replication Stress and Homologous Recombination” Poster Presentation, Abstract # 63

American Society of Hematology (ASH) 2011, San Diego, California, Dec 10th to Dec 13th, 2011. “A Randomized Clinical Trial of Lenalidomide and Dexamethasone With and Without Autologous Stem Cell Transplant in Patients with Newly Diagnosed Multiple Myeloma: Interim Study Results”. Poster Presentation, Abstract # 4142

American Society of Hematology (ASH) 2011, San Diego, California, Dec 10th to Dec 13th, 2011. “Combination of Bendamustine, Lenalidomide, and Dexamethasone (BLD) in Patients with Refractory or Relapsed MM Is Safe and Highly Effective: Results of Phase I/II Open-Label, Dose Escalation Study.” Oral Presentation Abstract # 304

Getting Personal:

Hobbies and Interest – Soccer, Hiking & Camping, Fishing, Backgammon